|
NTRA | Natera, Inc. |
|
|
NTRA | Natera, Inc. |
| Services-Medical Laboratories |
| Book value per $ invested | $ 0.05 |
| Leverage | 29.08% |
| Market Cap | $ 23.3B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -252.7m |
| Margin | -12.90% |
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.